Recent Finacing
Recent Raise
TearExo develops a tear-fluid exosome sensing platform using hybrid molecular-recognition/antibody chips and a reagent-free paper-strip sampling workflow, with an automated prototype and breast-cancer IVD kit scale-up and PMDA approval.
Focus Areas
Recent Investors
Funding round
Investor